leadf
logo-loader
NYSE:NBY

NovaBay Pharmaceuticals, Inc.

Receive alerts
Market:
NYSE
Market Cap:
$26.53 m
Price
0.64 USD
Change
-2.32%
52 weeks high
1.93
52 weeks low
0.28

In brief

NovaBay Pharmaceuticals is a clinical stage company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections.